Exercise preconditioning prevents left ventricular dysfunction and remodeling in monocrotaline-induced pulmonary hypertension
Open Access
- 1 September 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Porto Biomedical Journal
- Vol. 5 (5) , e081
Abstract
Background: Despite pulmonary arterial hypertension (PAH) directly affects the right ventricle (RV), important structural, functional, and molecular changes also occur in left ventricle (LV). The objective of our study was to analyze the hypothetical cardioprotective effects of exercise preconditioning on LV in rats with monocrotaline (MCT)-induced PAH. Methods: Forty male Wistar rats were randomly separated in sedentary (SED) and trained group (EX; running sessions of 60 min/day, 5 days/wk, at 25 m/min, for 4 weeks). After 4 weeks, animals were injected with MCT (60 mg/kg; SED + MCT; EX + MCT) or vehicle (SED + V). Following an additional period of 4 weeks where all animals remained sedentary, we completed LV hemodynamic evaluation in baseline and isovolumic conditions and collected LV samples for histological and molecular analysis. Results: Preconditioning with exercise was capable to restore LV systolic and diastolic dysfunction in both baseline and isovolumic conditions (P < .05). This improved was paralleled with prevention of LV cardiomyocytes atrophy, fibrosis, and endothelin 1 mRNA levels (P < .05). Conclusions: Our findings suggest that exercise preconditioning can prevent LV dysfunction secondary to MCT-induced PAH, which is of particular interest for the familial form of the disease that is manifested by greater severity or earlier onset.Keywords
This publication has 30 references indexed in Scilit:
- New Targets to Treat the Structural Remodeling of the MyocardiumJACC, 2011
- Cellular mechanisms of cardiomyopathyJournal of Cell Biology, 2011
- Opposite Effects of Training in Rats With Stable and Progressive Pulmonary HypertensionCirculation, 2009
- EFFECTS OF A CHRONIC EXERCISE TRAINING PROTOCOL ON OXIDATIVE STRESS AND RIGHT VENTRICULAR HYPERTROPHY IN MONOCROTALINE‐TREATED RATSClinical and Experimental Pharmacology and Physiology, 2008
- Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Loss of exercise-induced cardioprotection after cessation of exerciseJournal of Applied Physiology, 2004
- Chronic pulmonary hypertension‐the monocrotaline model and involvement of the hemostatic systemJournal of Toxicology and Environmental Health, Part B, 1998
- The Effects of Endothelin-1 on Collagen Type I and Type III Synthesis in Cultured Porcine Coronary Artery Vascular Smooth Muscle CellsJournal of Molecular and Cellular Cardiology, 1996
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988